N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidino]ethyl]-4-fluorobenzamide

CAS: 59831-65-1

Ref. 3D-FC145515

Información del producto

• Nombre: N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidino]ethyl]-4-fluorobenzamide
• Sinónimos: Halopemide, 59831-65-1, N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-4-fluorobenzamide, N-{2-[4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]ethyl}-4-fluorobenzamide

Descripción

N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidino]ethyl]-4-fluorobenzamide (NFA) is a novel benzodiazepine receptor inverse agonist that has been shown to be a potent inhibitor of fatty acid synthase in vitro and in vivo. NFA has been shown to inhibit the production of gamma aminobutyric acid (GABA) with an IC50 value of 0.8 nM. This drug binds to the GABA receptor with high affinity and inhibits the binding of GABA, which is responsible for its anti-anxiety effects. NFA also blocks the binding of dopamine and other drugs to their receptors, which may contribute to its antidepressant properties.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 416.88 g/mol
• Fórmula: C₂₁H₂₂ClFN₄O₂
• Pureza: Min. 95%